Massimo Puoti

Summary

Country: Italy

Publications

  1. ncbi request reprint Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals
    Giorgio Antonucci
    National Institute of Infectious Diseases, L Spallanzani, Rome, Italy
    Clin Infect Dis 40:e101-9. 2005
  2. ncbi request reprint Natural history of chronic hepatitis B in co-infected patients
    Massimo Puoti
    Clinica di Malattie Infettive e Tropicali, AO Spedali Civili, Universita di Brescia, P zzle Spedali Civili 1, I 25123 Brescia, Italy
    J Hepatol 44:S65-70. 2006
  3. pmc Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy
    Giorgio Antonucci
    Italian Society of Infectious and Tropical Diseases, Florence, Italy
    BMC Res Notes 6:153. 2013
  4. pmc Future research and collaboration: the "SINERGIE" project on HCV (South Italian Network for Rational Guidelines and International Epidemiology)
    C Torti
    Unit of Infectious Diseases, University Magna Graecia, Catanzaro, Italy
    BMC Infect Dis 12:S9. 2012
  5. pmc Top topics in HCV research arena
    Massimo Puoti
    Infectious Diseases Unit AO Ospedale Niguarda Ca Granda, 20162 Milano, Italy
    BMC Infect Dis 12:S7. 2012
  6. doi request reprint The burden of liver disease in human immunodeficiency virus-infected patients
    Massimo Puoti
    Department of Infectious Diseases, AO Ospedale Niguarda Ca Granda, Milano, Italy
    Semin Liver Dis 32:103-13. 2012
  7. doi request reprint Hepatocellular carcinoma in HIV hepatitis C virus
    Massimo Puoti
    Department of Infectious Diseases, AO Ospedale Niguarda Ca Granda, Milano, Italy
    Curr Opin HIV AIDS 6:534-8. 2011
  8. ncbi request reprint [Update on the diagnosis and therapy of blood-transmitted occupational infections]
    Massimo Puoti
    Istituto di Malattie Infettive e Tropicali, Universita degli Studi di Brescia, Italy
    G Ital Med Lav Ergon 32:245-8. 2010
  9. doi request reprint HIV-related liver disease: ARV drugs, coinfection, and other risk factors
    Massimo Puoti
    Department of Infectious and Tropical Diseases, University of Brescia, AO Spedali Civili, Brescia, Italy
    J Int Assoc Physicians AIDS Care (Chic) 8:30-42. 2009
  10. doi request reprint Hepatitis B virus and HIV coinfection in low-income countries: unmet needs
    Massimo Puoti
    Department of Infectious Diseases, University of Brescia, Italy
    Clin Infect Dis 46:367-9. 2008

Detail Information

Publications58

  1. ncbi request reprint Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals
    Giorgio Antonucci
    National Institute of Infectious Diseases, L Spallanzani, Rome, Italy
    Clin Infect Dis 40:e101-9. 2005
    ..We also aimed to assess whether the response to HAART in these patients varied according to HCV genotype...
  2. ncbi request reprint Natural history of chronic hepatitis B in co-infected patients
    Massimo Puoti
    Clinica di Malattie Infettive e Tropicali, AO Spedali Civili, Universita di Brescia, P zzle Spedali Civili 1, I 25123 Brescia, Italy
    J Hepatol 44:S65-70. 2006
    ....
  3. pmc Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy
    Giorgio Antonucci
    Italian Society of Infectious and Tropical Diseases, Florence, Italy
    BMC Res Notes 6:153. 2013
    ....
  4. pmc Future research and collaboration: the "SINERGIE" project on HCV (South Italian Network for Rational Guidelines and International Epidemiology)
    C Torti
    Unit of Infectious Diseases, University Magna Graecia, Catanzaro, Italy
    BMC Infect Dis 12:S9. 2012
    ..The final objective is to assist in improving care delivery and inform Public Health Authorities on how to optimize resource allocation in this area...
  5. pmc Top topics in HCV research arena
    Massimo Puoti
    Infectious Diseases Unit AO Ospedale Niguarda Ca Granda, 20162 Milano, Italy
    BMC Infect Dis 12:S7. 2012
    ..However, data observed in interferon experienced patients are less exciting and probably more complex treatment regimens will be needed to treat this patients' population...
  6. doi request reprint The burden of liver disease in human immunodeficiency virus-infected patients
    Massimo Puoti
    Department of Infectious Diseases, AO Ospedale Niguarda Ca Granda, Milano, Italy
    Semin Liver Dis 32:103-13. 2012
    ..Finally, acute hepatitis A virus (HAV) and acute and even chronic hepatitis E virus infection have also been reported as causes of liver damage in HIV. Anti-HAV vaccination is thus recommended in persons at risk living with HIV...
  7. doi request reprint Hepatocellular carcinoma in HIV hepatitis C virus
    Massimo Puoti
    Department of Infectious Diseases, AO Ospedale Niguarda Ca Granda, Milano, Italy
    Curr Opin HIV AIDS 6:534-8. 2011
    ..This review analyzes the main data published on HCC in PLHIV in the last 3 years...
  8. ncbi request reprint [Update on the diagnosis and therapy of blood-transmitted occupational infections]
    Massimo Puoti
    Istituto di Malattie Infettive e Tropicali, Universita degli Studi di Brescia, Italy
    G Ital Med Lav Ergon 32:245-8. 2010
    ....
  9. doi request reprint HIV-related liver disease: ARV drugs, coinfection, and other risk factors
    Massimo Puoti
    Department of Infectious and Tropical Diseases, University of Brescia, AO Spedali Civili, Brescia, Italy
    J Int Assoc Physicians AIDS Care (Chic) 8:30-42. 2009
    ..As more information about the mechanisms of drug related liver injury is known, clinicians will be better able to tailor therapies to suit individual situations, resulting in greater patient safety and outcomes...
  10. doi request reprint Hepatitis B virus and HIV coinfection in low-income countries: unmet needs
    Massimo Puoti
    Department of Infectious Diseases, University of Brescia, Italy
    Clin Infect Dis 46:367-9. 2008
  11. ncbi request reprint Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients
    Carlo Torti
    School of Medicine, Institute for Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    Drug Saf 30:1161-9. 2007
    ..Moreover, the predictive value of gender and CD4+ T-cell count on the risk of raised transaminase levels has been poorly investigated in populations of patients co-infected with hepatitis C virus (HCV)...
  12. ncbi request reprint Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV
    Eugenia Quiros-Roldan
    Institute for Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    Antivir Ther 13:341-8. 2008
    ..The efficacy of long-term hepatitis B virus (HBV) treatment with tenofovir (TDF) in relation to lamivudine (LMV) resistance in HIV patients failing on LMV deserves further investigations...
  13. doi request reprint Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a
    Paola Nasta
    Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    AIDS 22:857-61. 2008
    ..To investigate the association between insulin resistance and rapid virologic response...
  14. ncbi request reprint Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort
    Carlo Torti
    Istituto di Malattie Infettive e Tropicali, Universita di Brescia, Brescia, Italy
    J Acquir Immune Defic Syndr 41:180-5. 2006
    ..The independent role of hepatitis C virus (HCV) genotype 3 in liver transaminase elevation following highly active antiretroviral regimens is still controversial...
  15. pmc Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort
    Carlo Torti
    Istituto di Malattie Infettive e Tropicali, Universita degli Studi di Brescia, p le Spedali Civili 1, Brescia, Italy
    BMC Infect Dis 5:58. 2005
    ....
  16. ncbi request reprint Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome
    Massimo Puoti
    Istituto di Malattie Infettive e Tropicali, Universita degli Studi di Brescia, Italy
    J Acquir Immune Defic Syndr 32:259-67. 2003
    ..To assess incidence, risk factors, histology, and outcome of severe hepatotoxicity (SH) during antiretroviral treatment (ART)...
  17. ncbi request reprint Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy
    Giuseppe Lapadula
    Istituto per le Malattie Infettive e Tropicali, Universita di Brescia, Brescia, Italy
    Antivir Ther 11:521-7. 2006
    ..The independent role of HCV genotype 3 (HCV-3) in dyslipidaemia following highly active antiretroviral therapy (HAART) is still unexplored...
  18. doi request reprint Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis
    Francesca Gatti
    Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    J Antimicrob Chemother 63:575-8. 2009
    ..Liver stiffness at baseline and alanine aminotransferase levels at baseline and during follow-up were measured in order to find a correlation between drug levels and liver fibrosis or hepatotoxicity...
  19. ncbi request reprint Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation?
    Massimo Puoti
    Department of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    Antivir Ther 9:627-30. 2004
    ..In summary, use of pegylated interferon appears to increase the risk of non-respiratory infections independently from neutropenia...
  20. ncbi request reprint Treating hepatitis C virus in HIV patients: are side effects a real obstacle?
    Francesca Gatti
    Department of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    AIDS Rev 9:16-24. 2007
    ....
  21. doi request reprint Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop
    Giampiero Carosi
    Department of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    Dig Liver Dis 43:259-65. 2011
    ....
  22. doi request reprint Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients
    Giulia Morsica
    Department of Infectious Diseases, San Raffaele, Scientific Institute, Milan, Italy
    J Acquir Immune Defic Syndr 51:574-81. 2009
    ..To investigate the reciprocal inhibitory effects of hepatitis B virus (HBV)/hepatitis C virus (HCV)/hepatitis D virus (HDV) infections in naive and previously antiretroviral-experienced HIV-positive patients...
  23. ncbi request reprint Comment to the editorial: Liver biopsy in HIV-infected patients with chronic hepatitis C: pros and cons, by Vincent Soriano and Javier García-Samaniego
    Massimo Puoti
    Department of Infectious Diseases, University of Brescia AO Spedali Civili, Brescia, Italy
    HIV Clin Trials 3:419-20. 2002
  24. ncbi request reprint Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis
    Massimo Puoti
    Clinica di Malattie Infettive e Tropical, Universita degli Studi di Brescia, Brescia, Italy
    Antivir Ther 11:567-74. 2006
    ..The impact of lamivudine (3TC) as part of combination antiretroviral therapy (cART) on the risk of liver-related death (LRD) in HIV/hepatitis B virus (HBV)-coinfected patients has not been extensively studied...
  25. ncbi request reprint Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection
    Carlo Torti
    Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    Antivir Ther 9:139-42. 2004
  26. ncbi request reprint A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients
    Massimo Puoti
    Clinica di Malattie Infettive e Tropicali, AO Spedali Civili di Brescia, Universita di Brescia, Brescia, Italy
    J Hepatol 41:312-8. 2004
    ..To assess the impact of intensification of interferon administration and of the addition of amantadine on the efficacy and safety of standard anti-hepatitis C virus (HCV) treatment in HIV-infected patients...
  27. ncbi request reprint The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug?
    Massimo Puoti
    Institute of Infectious and Tropical Diseases, Spedali Civili, University of Brescia, Brescia, Italy
    Antivir Ther 9:811-7. 2004
    ..3; -131.7, P=0.003] and a significantly reduced risk of liver-related morbidity/mortality [Relative hazard (RH)=0.07; 95% CI: 0.01-0.38, P=0.002] than those starting a lamivudine sparing-regimen...
  28. doi request reprint The epidemiological pattern of chronic liver diseases in a community undergoing voluntary screening for hepatitis B and C
    Claudia Zani
    Department of Experimental and Applied Medicine, Institute of Hygiene, Epidemiology and Public Health, University of Brescia, Italy
    Dig Liver Dis 43:653-8. 2011
    ..The aim of this study was to estimate the prevalence of chronic liver diseases and their aetiology in the area...
  29. ncbi request reprint Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop
    Giampiero Carosi
    Department of Infectious Disease, University of Brescia, Brescia, Italy
    AIDS Rev 7:161-7. 2005
    ....
  30. doi request reprint Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature
    Stefania Zingarelli
    Rheumatology and Clinical Immunology Service, Infectious and Tropical Diseases Department, Spedali Civili and University of Brescia, Brescia, Italy
    J Rheumatol 36:1188-94. 2009
    ....
  31. ncbi request reprint Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study
    Andrea Patroni
    Institute of Infectious and Tropical Diseases, University of Brescia, Italy
    HIV Clin Trials 3:451-61. 2002
    ..Lipid disturbances have also been associated with hepatitis C virus (HCV) chronic infection in HIV-uninfected participants. HAART-induced lipid abnormalities may then have peculiar features in HIV-HCV co-infected individuals...
  32. ncbi request reprint Hepatitis A in men having sex with men (MSMs) in northern Italy
    Alessandro Pini
    Institute for Infectious and Tropical Diseases, University of Brescia, Italy
    Infez Med 18:113-4. 2010
    ..Some of our HAV cases occurred in HIV-infected subjects. This observation underlines the action of HAV as a sexually transmitted infection and urges preventive measures, such as routine HAV vaccination in the HIV-infected population...
  33. ncbi request reprint The burden of HIV and hepatitis C virus coinfection
    Massimo Puoti
    Department of Infectious Diseases, University of Brescia, Brescia, Italy
    Curr Opin HIV AIDS 2:460-5. 2007
    ..Persons with HIV are frequently coinfected with hepatitis C virus. We review recent data on the epidemiology and natural history of hepatitis C in HIV-infected persons...
  34. ncbi request reprint Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV
    Massimo Puoti
    Clinica di Malattie Infettive e Tropicali Università degli Studi di Brescia AO Spedali Civili, Brescia, Italy
    HIV Clin Trials 3:324-32. 2002
    ..The search for the perfect treatment continues...
  35. doi request reprint Rhinoscleroma in an immigrant from Egypt: a case report
    Edgardo Bonacina
    Department of Pathological Anatomy, Niguarda Ca Granda Hospital, Milano, Italy
    J Travel Med 19:387-90. 2012
    ..We would postulate that with increased travel from areas where rhinoscleroma is endemic to other non-endemic areas, diagnosis of this condition will become more common...
  36. ncbi request reprint Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'e-minus' patients with YMDD mutations after 4 weeks of tenofovir therapy
    Raffaele Bruno
    AIDS 17:783-4. 2003
  37. doi request reprint Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel
    Vincent Soriano
    Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain
    AIDS 22:1399-410. 2008
    ..The present study represents an update of the current knowledge about HBV/HIV coinfection and an intent to provide practical advise about how to give the best care to HIV-infected persons with chronic hepatitis B...
  38. ncbi request reprint Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC)
    Claudio Puoti
    Department of Gastroenterology and Internal Medicine, Genzano Hospital, Via Cimone 171, 00141 Rome, Italy
    J Hepatol 37:117-23. 2002
    ..To evaluate demographic characteristics, liver histology and virological features of hepatitis C virus (HCV) carriers with normal alanine transaminase (ALT) levels...
  39. ncbi request reprint Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects
    Andrea De Luca
    Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy
    Arch Intern Med 162:2125-32. 2002
    ..The effect of chronic coinfection with hepatitis viruses on the response to therapy against human immunodeficiency virus 1 (HIV-1) remains debated...
  40. ncbi request reprint HCV chronic hepatitis in patients with HIV: clinical management issues
    Raffaele Bruno
    Division of Infectious and Tropical Disease, IRCCS S Matteo Hospital, University of Pavia, Italy
    Am J Gastroenterol 97:1598-606. 2002
    ..Liver transplantation in HIV patients is currently under evaluation, but should become the rescue therapy for HIV patients with end stage liver disease...
  41. ncbi request reprint Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study
    Luz Martin-Carbonero
    Hospital Carlos III, Madrid, Spain
    Clin Infect Dis 38:128-33. 2004
    ..The rate of complications due to end-stage liver disease will inevitably increase in this population, for whom anti-HCV therapy should be considered a priority...
  42. ncbi request reprint Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future
    Marina Nunez
    Service of Infectious Diseases, Hospital Carlos III, Madrid, Spain
    Clin Infect Dis 37:1678-85. 2003
    ..Preliminary results with some of them are quite promising and probably will widen the therapeutic armamentarium against hepatitis B in patients with HIV infection...
  43. ncbi request reprint Pathogenesis of liver damage in HCV-HIV patients
    Raffaele Bruno
    Division of Infectious and Tropical Diseases, Fondazione IRCCS San Matteo Hospital, University of Pavia, Pavia, Italy
    AIDS Rev 10:15-24. 2008
    ....
  44. ncbi request reprint Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome
    Massimo Puoti
    FClinica di Malattie Infettive, Università degli Studi di Brescia AO Spedali Civili, Brescia, Clinica di Malattie Infettive e Tropicali, Madrid, Spain
    AIDS 18:2285-93. 2004
    ..Hepatocellular carcinoma (HCC) is an increasing cause of mortality in HIV-seropositive individuals. The aim of the study was to compare the main features of HCC in HIV-seropositive individuals with those in to HIV-negative patients...
  45. ncbi request reprint Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
    Paola Cicconi
    Clinic of Infectious Diseases and Tropical Medicine University of Milan, Milan, Italy
    AIDS 21:599-606. 2007
    ..To investigate if the risk of liver enzyme elevation (LEE) in HIV/hepatitis B or C (HBV, HCV) co-infection is altered by HAART (two or more drugs)...
  46. ncbi request reprint Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?
    Marco Bongiovanni
    Clinic of Infectious Diseases, San Paolo Hospital, University of Milan, Milan, Italy
    Clin Infect Dis 45:650-3. 2007
    ....
  47. ncbi request reprint Antiretroviral drugs and liver injury
    Vincent Soriano
    AIDS 22:1-13. 2008
  48. ncbi request reprint Influence of hepatitis C virus coinfection on lipid abnormalities in HIV-positive patients after highly active antiretroviral therapy
    Carlo Torti
    J Acquir Immune Defic Syndr 29:315-7. 2002
  49. ncbi request reprint Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection
    Raffaele Bruno
    Division of Infectious and Tropical Diseases, Instituto di Ricerca e Cura a Carattere Scientifico, San Matteo Hospital, University of Pavia, Italy
    J Acquir Immune Defic Syndr 46:297-303. 2007
    ..This study was designed to investigate the incidence and type of liver-related complications and mortality in coinfected cirrhotic patients...
  50. ncbi request reprint Care of patients with hepatitis C and HIV co-infection
    Vincent Soriano
    AIDS 18:1-12. 2004
  51. ncbi request reprint Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients
    Raffaele Bruno
    Division of Infectious and Tropical Diseases, IRCCS San Matteo Hospital, University of Pavia, Pavia, Italy
    J Hepatol 44:S146-50. 2006
    ..Prevention of hepatitis and cirrhosis are key goals in reducing the impact of HCC. Numerous issues in HCC prevention, diagnosis, and management still remain to be resolved through large-scale, randomized clinical trials...
  52. ncbi request reprint Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects
    Massimo Puoti
    Clinica di Malattie Infecttive e Tropicali, Università degli studi de Brescia, AO Spedali Civili dei Brescia
    AIDS Rev 4:27-35. 2002
    ..Highly Active Anti-Hepatitis B Therapy will probably soon come of age...
  53. ncbi request reprint Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel
    Vincent Soriano
    Department of Infectious Diseases, Hospital Carlos III, Calle Sinesio Delgado 10, 28029 Madrid, Spain
    AIDS 19:221-40. 2005
  54. ncbi request reprint CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice--clinical implications for CCR5 inhibition as antiretroviral therapy
    Stefan Mauss
    Hepatology 43:879; author reply 879-80. 2006
  55. ncbi request reprint Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis: an emerging issue
    Raffaele Bruno
    J Acquir Immune Defic Syndr 30:535-6. 2002
  56. ncbi request reprint Impact of hepatitis C virus infection on lifestyle
    Paola Scognamiglio
    Istituto Nazionale per le Malattie Infettive, L Spallanzani IRCCS, Via Portuense 292, Roma 00149, Italy
    World J Gastroenterol 13:2722-6. 2007
    ..To evaluate the impact of the diagnosis of hepatitis C infection on lifestyle habits such as smoking, drinking, sports activity and diet...
  57. pmc Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C
    Raffaele Bruno
    Division of Infectious and Tropical Disease IRCCS San Matteo Hospital, University of Pavia, Pavia, Italy
    BMC Infect Dis 2:17. 2002
    ..In HIV patients the use of this combination therapy may induce drug interactions, and reduces the adherence to HAART. The aim of this study is to evaluate safety and efficacy of a 48 weeks daily dose IFN schedule...
  58. ncbi request reprint Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel
    Vincent Soriano
    Department of Infectious Diseases, Hospital Carlos III, Calle Sinesio Delgado 10, 28029 Madrid, Spain
    AIDS 21:1073-89. 2007